Effects of milk and yogurt on bone health and body composition in young adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how supplementation with milk and yogurt affects bone health and body composition in Canadian young adults aged 19 to 30 years. Participants with low dietary calcium intake will be assigned to consume either milk or yogurt alongside their habitual diet over a 24-month period. The research aims to fill the knowledge gap regarding the long-term impact of these dairy products on obesity and osteoporosis, which are significant public health concerns in Canada. By examining the role of probiotics and key nutrients in dairy, the study seeks to provide insights into improving health outcomes in this age group.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 19-30 years old
* Dietary calcium intake below 1000mg/ day
* living in the Saskatoon area (Saskatchewan, Canada)

Exclusion Criteria:

* Calcium intake from both food and supplement above the estimated average requirement (EAR) for adults aged 19-30 years (\>800 mg/day)
* Total dairy intake of more than 1 serving per day
* Body mass index greater than to 30 kg/m2
* Medical history of metabolic bone, liver, endocrine, connective tissue, and respiratory diseases, thyroid disorders, or cancer
* Diagnosed cases with secondary osteoporosis due to hypoparathyroidism
* Hormonal disorders or disturbances
* Taking medications known to influence bone mass and density (e.g., steroids, diuretics, heparin, and cancer drugs)
* Cow's milk allergy
* Pregnant or lactating women, or those planning to conceive during the duration of the trial

Where it's running

• University of Saskatchewan
  Saskatoon, Saskatchewan, Canada Recruiting

Study contacts

• Principal investigator: Hassan Vatanparast, MD, PhD — University of Saskatchewan
• Study coordinator: Hassan Vatanparast, MD, PhD
• Email: vatan.h@usask.ca
• Phone: 306-966-8866

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• GLP-1 drug effects on muscle and bone during weight loss

  It tests whether GLP-1–based weight-loss medication (tirzepatide) plus a lifestyle program changes muscle and bone in adults 18–50 with obesity (BMI 30–40).

  Recruiting Phase 4 Pennington Biomedical Research Center · Baton Rouge, Louisiana and 1 other locations · NCT07154719

• China health screening using low-dose chest CT to measure spine bone density and body/liver fat

  This project uses low-dose chest CT scans and QCT to test whether spine bone density, visceral fat, and liver fat can be measured in adults getting routine health checks across China.

  Recruiting at 6 sites Beijing Jishuitan Hospital · Wuhu, Anhui and 5 other locations · NCT03699228

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.